Convergence Investment Partners’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.52M | Sell |
21,372
-4,782
| -18% | -$1.03M | 0.74% | 35 |
|
|
2025
Q4 | $5.37M | Sell |
26,154
-3,362
| -11% | -$633K | 1.07% | 17 |
|
|
2025
Q3 | $4.63M | Sell |
29,516
-1,602
| -5% | -$247K | 1.04% | 19 |
|
|
2025
Q2 | $5.23M | Buy |
31,118
+1,667
| +6% | +$247K | 1.33% | 12 |
|
|
2025
Q1 | $4.06M | Sell |
29,451
-3,674
| -11% | -$468K | 1.12% | 19 |
|
|
2024
Q4 | $3.92M | Buy |
33,125
+8,023
| +32% | +$937K | 0.88% | 26 |
|
|
2024
Q3 | $2.77M | Buy |
25,102
+8,352
| +50% | +$873K | 0.75% | 36 |
|
|
2024
Q2 | $1.65M | Sell |
16,750
-13,887
| -45% | -$1.42M | 0.48% | 57 |
|
|
2024
Q1 | $3.43M | Buy |
30,637
+2,249
| +8% | +$243K | 1.31% | 19 |
|
|
2023
Q4 | $2.86M | Sell |
28,388
-1,164
| -4% | -$115K | 1.5% | 12 |
|
|
2023
Q3 | $2.57M | Sell |
29,552
-4,504
| -13% | -$407K | 1.52% | 16 |
|
|
2023
Q2 | $3.22M | Sell |
34,056
-607
| -2% | -$51.3K | 1.85% | 7 |
|
|
2023
Q1 | $2.62M | Sell |
34,663
-323
| -0.9% | -$24.4K | 1.54% | 13 |
|
|
2022
Q4 | $2.69M | Buy |
34,986
+655
| +2% | +$49.8K | 1.59% | 12 |
|
|
2022
Q3 | $2.29M | Sell |
34,331
-847
| -2% | -$53.7K | 1.49% | 14 |
|
|
2022
Q2 | $1.84M | Buy |
35,178
+3,698
| +12% | +$210K | 1.11% | 24 |
|
|
2022
Q1 | $1.78M | Buy |
31,480
+265
| +0.8% | +$14.2K | 0.92% | 36 |
|
|
2021
Q4 | $1.61M | Buy |
31,215
+3,828
| +14% | +$188K | 0.82% | 38 |
|
|
2021
Q3 | $1.35M | Sell |
27,387
-9,359
| -25% | -$508K | 0.73% | 50 |
|
|
2021
Q2 | $2.1M | Buy |
36,746
+66
| +0.2% | +$3.86K | 0.9% | 34 |
|
|
2021
Q1 | $2.23M | Sell |
36,680
-5,905
| -14% | -$326K | 1.02% | 27 |
|
|
2020
Q4 | $2.28M | Sell |
42,585
-21,198
| -33% | -$1.1M | 1.15% | 21 |
|
|
2020
Q3 | $3M | Sell |
63,783
-2,005
| -3% | -$103K | 1.04% | 20 |
|
|
2020
Q2 | $3.43M | Buy |
65,788
+2,499
| +4% | +$129K | 1.18% | 16 |
|
|
2020
Q1 | $3.03M | Sell |
63,289
-1,604
| -2% | -$83.3K | 1.33% | 14 |
|
|
2019
Q4 | $3.28M | Buy |
64,893
+1,480
| +2% | +$76.4K | 0.93% | 27 |
|
|
2019
Q3 | $2.99M | Sell |
63,413
-8,347
| -12% | -$381K | 0.83% | 30 |
|
|
2019
Q2 | $3.38M | Sell |
71,760
-1,443
| -2% | -$66.6K | 0.82% | 33 |
|
|
2019
Q1 | $3.52M | Sell |
73,203
-1,630
| -2% | -$81.7K | 0.77% | 29 |
|
|
2018
Q4 | $3.34M | Buy |
74,833
+44,921
| +150% | +$2.34M | 0.77% | 31 |
|
|
2018
Q3 | $1.61M | Buy |
29,912
+5,335
| +22% | +$273K | 0.33% | 114 |
|
|
2018
Q2 | $1.2M | Sell |
24,577
-404
| -2% | -$22.9K | 0.17% | 164 |
|
|
2018
Q1 | $1.57M | Buy |
24,981
+6,243
| +33% | +$428K | 0.2% | 171 |
|
|
2017
Q4 | $1.15M | Sell |
18,738
-19,864
| -51% | -$1.23M | 0.15% | 227 |
|
|
2017
Q3 | $2.58M | Buy |
+38,602
| New | +$2.73M | 0.37% | 96 |
|
|
2017
Q2 | – | Sell |
-33,265
| Closed | -$2.71M | – | 347 |
|
|
2017
Q1 | $2.71M | Buy |
33,265
+26,824
| +416% | +$2.11M | 0.38% | 95 |
|
|
2016
Q4 | $464K | Sell |
6,441
-27,344
| -81% | -$1.98M | 0.06% | 277 |
|
|
2016
Q3 | $2.63M | Sell |
33,785
-6,882
| -17% | -$556K | 0.39% | 88 |
|
|
2016
Q2 | $3.17M | Buy |
40,667
+36,570
| +893% | +$2.92M | 0.44% | 80 |
|
|
2016
Q1 | $336K | Buy |
+4,097
| New | +$333K | 0.04% | 310 |
|
|
2015
Q3 | – | Sell |
-58,836
| Closed | -$4.92M | – | 351 |
|
|
2015
Q2 | $4.92M | Buy |
58,836
+30,434
| +107% | +$2.69M | 0.49% | 57 |
|
|
2015
Q1 | $2.56M | Buy |
+28,402
| New | +$2.45M | 0.36% | 94 |
|
|
2014
Q4 | – | Sell |
-18,345
| Closed | -$1.37M | – | 369 |
|
|
2014
Q3 | $1.37M | Buy |
+18,345
| New | +$1.33M | 0.19% | 174 |
|
|
2014
Q1 | – | Sell |
-3,009
| Closed | -$201K | – | 373 |
|
|
2013
Q4 | $201K | Sell |
3,009
-14,246
| -83% | -$871K | 0.03% | 359 |
|
|
2013
Q3 | $900K | Sell |
17,255
-33,887
| -66% | -$1.72M | 0.19% | 157 |
|
|
2013
Q2 | $2.41M | Buy |
+51,142
| New | +$2.34M | 0.63% | 34 |
|
Other funds holding CAH
VCM
VPM
Convergence Investment Partners's CAH Position: Q1 2026 in Review
Convergence Investment Partners reduced its Cardinal Health (CAH) stake by 18% in Q1 2026, selling an estimated $1.03M and leaving 21,372 shares worth $4.52M. The position accounts for 0.74% of the portfolio, ranked #35.
Convergence Investment Partners first reported a position in CAH in Q2 2013 and has held it in 46 quarters since. The position peaked at $5.37M in Q4 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Convergence Investment Partners held 21,372 shares of Cardinal Health worth $4.52M as of Q1 2026.
- Convergence Investment Partners sold 4,782 Cardinal Health shares in Q1 2026, an estimated $1.03M.
- Cardinal Health made up 0.74% of Convergence Investment Partners's portfolio in Q1 2026, its #35 holding.
- Convergence Investment Partners first reported a position in Cardinal Health in Q2 2013 and has held it in 46 quarters since.
- Convergence Investment Partners's Cardinal Health position peaked at $5.37M in Q4 2025.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Convergence Investment Partners's 13F filing for Q1 2026, filed 7 May 2026.